Summary
Background
Diabetic foot complications, one of the most severe late complications of type 2 diabetes mellitus, are associated with a tremendous personal and financial burden. In order to drive the prevention of diabetic foot complications forward and facilitate early detection and personalized screening of high-risk patients, longitudinal studies are needed to identify risk factors associated with diabetic foot complications in large patient datasets.
Methods
This is a retrospective cohort study on 3002 patients with type 2 diabetes mellitus aged ≥ 18 years without prior foot complications. The data were collected between 2006 and 2017 in an Austrian hospital department specialized for diabetic patients. In addition to a univariate Cox regression analysis, multivariate Cox regression models were established to identify independent risk factors associated with diabetic foot complications and adjust for potential confounders.
Results
We observed a total of 61 diabetic foot complications in 3002 patients. In the multivariate Cox regression model, significant risk factors (hazard ratio, 95% confidence interval) for foot complications were age at diagnosis > 70 years (3.39, 1.33–8.67), male gender (2.55, 1.42–4.55), neuropathy (3.03, 1.74–5.27), peripheral arterial disease (3.04, 1.61–5.74), hypertension > 10 years after diagnosis (2.32, 1.09–4.93) and HbA1c > 9% (2.44, 1.02–5.83).
Conclusion
The identified risk factors for diabetic foot complications suggest that personalized early detection of patients at high risk might be possible by taking the patient’s clinical characteristics, medical history and comorbidities into account. Modifiable risk factors, such as hypertension and high levels of blood glucose might be tackled to reduce the risk for diabetic foot complications.
Similar content being viewed by others
References
Federation IDIDF. Diabetes Atlas. 9th ed. 2019.
Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment. Diabetes Care. 2008;31(8):1679–85.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28.
Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826.
Volmer-Thole M, Lobmann R. Neuropathy and diabetic foot syndrome. IJMS. 2016;17(6):917.
van Netten JJ, Bus SA, Apelqvist J, Lipsky BA, Hinchliffe RJ, Game F, et al. Definitions and criteria for diabetic foot disease. Diabetes Metab Res Rev. 2019;36(S1):e3268. https://doi.org/10.1002/dmrr.3268
Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med. 1996;13(11):967–72.
Sekhar MS, Thomas RR, Unnikrishnan M, Vijayanarayana K, Rodrigues GS, editors. Impact of diabetic foot ulcer on health-related quality of life: A cross-sectional study. Seminars in Vascular Surgery. 2015;28(3/4):165–71. https://doi.org/10.1053/j.semvascsurg.2015.12.001
de Meneses LC, Blanes L, Francescato Veiga D, Carvalho Gomes H, Ferreira ML. Health-related quality of life and self-esteem in patients with diabetic foot ulcers: results of a cross-sectional comparative study. Ostomy Wound Manag. 2011;57(3):36.
Salomé GM, de Souza Pellegrino DM, Blanes L, Ferreira LM. Self-esteem in patients with diabetes mellitus and foot ulcers. J Tissue Viability. 2011;20(3):100–6.
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–88.
Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29(7):855–62.
Jeffcoate WJ, Harding KG. Diabetic foot ulcers. lancet. 2003;361(9368):1545–51.
Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg. 2010;52(3):17S–22S.
Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75 % of foot ulcers are preventable. Diabetes Metab Res Rev. 2016;32:195–200.
Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1993;119(1):36–41.
Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;29(6):1202–7.
Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012;28(7):574–600.
Rossboth S, Lechleitner M, Oberaigner W. Risk factors for diabetic foot complications in type 2 diabetes—a systematic review. Endocrinol Diabetes Metab. 2020;4(1):e175. https://doi.org/10.1002/edm2.175
Sauseng S, Kästenbauer T, Sokol G, Irsigler K. Estimation of risk for plantar foot ulceration in diabetic patients with neuropathy. Diabetes Nutr Metab. 1999;12(3):189–93.
Kästenbauer T, Sauseng S, Sokol G, Auinger M, Irsigler K. A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc. 2001;91(7):343–50.
Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, et al. Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Value Health. 2017;20(8):1003–8.
Oberaigner W, Oberaigner K. Diabetesregister Tirol Gesamtbericht 2006–2010. Innsbruck: IET – Insitut für klinische Epidemiologie; 2011.
Harreiter J, Roden M. Diabetes mellitus–definition, klassifikation, diagnose, screening und prävention (update 2019). Wien Klin Wochenschr. 2019;131(1):6–15.
Radda S, Bolz M, Egger S, Gasser-Steiner V, Kralinger M, Mennel S, et al. Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung (Update 2019). Wien Klin Wochenschr. 2019;131(1):164–8.
Purnell JQ. Definitions, classification, and epidemiology of obesity. Endotext. 2018. MDText. https://www.ncbi.nlm.nih.gov/books/NBK279167/. Accessed 24. August 2020.
Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, et al. Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):27–38.
Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Berlin Heidelberg: Springer; 2010.
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–24.
Largay J. Case study: new-onset diabetes: how to tell the difference between type 1 and type 2 diabetes. Clin Diabetes. 2012;30(1):25–6.
Younis BB, Shahid A, Arshad R, Khurshid S, Ahmad M, Yousaf H. Frequency of foot ulcers in people with type 2 diabetes, presenting to specialist diabetes clinic at a Tertiary Care Hospital, Lahore, Pakistan. BMC Endocr Disord. 2018;18(1):53.
Lai YJ, Hu HY, Lin CH, Lee ST, Kuo SC, Chou P. Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001–2010. J Diabetes. 2015;7(2):260–7.
Sarfo-Kantanka O, Sarfo FS, Kyei I, Agyemang C, Mbanya JC. Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010–2015—a retrospective cohort study. Bmc Endocr Disord. 2019;19(1):27.
Sheen Y‑J, Kung P‑T, Kuo W‑Y, Chiu L‑T, Tsai W‑C. Impact of the pay-for-performance program on lower extremity amputations in patients with diabetes in Taiwan. Medicine. 2018;97(41):e12759.
Tseng C‑H. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor? CMAJ. 2006;174(3):319–23.
Venermo M, Manderbacka K, Ikonen T, Keskimäki I, Winell K, Sund R. Amputations and socioeconomic position among persons with diabetes mellitus, a population-based register study. BMJ Open. 2013;3(4). https://doi.org/10.1136/bmjopen-2012-002395
Baba M, Davis WA, Davis TME. A longitudinal study of foot ulceration and its risk factors in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2014;106(1):42–9.
Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013;30(8):964–72.
Hu H, Han C‑M, Hu X‑I, Ye W‑I, Huang W‑J, Smit AJ. Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects. J Zhejiang Univ Sci B. 2012;13(5):372–7.
Jiang Y, Wang X, Xia L, Fu X, Xu Z, Ran X, et al. A cohort study of diabetic patients and diabetic foot ulceration patients in China. Wound Rep and Reg. 2015;23(2):222–30.
Tuttolomondo A, Casuccio A, Guercio G, Maida C, Del Cuore A, Di Raimondo D, et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc Diabetol. 2017;16(1):2.
Zhao J, Deng W, Zhang Y, Zheng Y, Zhou L, Boey J, et al. Association between serum Cystatin C and diabetic foot ulceration in patients with type 2 diabetes: a cross-sectional study. J Diabetes Res. 2016;2016:8029340.
Callaghan BC, Feldman E, Liu J, Kerber K, Pop-Busui R, Moffet H, et al. Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care. 2011;34(3):635–40.
Humphrey AR, Dowse GK, Thoma K, Zimmet PZ. Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention—a 12-year follow-up study in Nauru. Diabetes Care. 1996;19(7):710–4.
Yang Y, Østbye T, Tan SB, Salam AZ‑H, Ong BC, Yang KS. Risk factors for lower extremity amputation among patients with diabetes in Singapore. J Diabetes Complicat. 2011;25(6):382–6.
Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;21(7):1071–5.
Dekker RG 2nd, Qin C, Ho BS, Kadakia AR. The effect of cumulative glycemic burden on the incidence of diabetic foot disease. J Orthop Surg Res. 2016;11(1):143.
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–16.
Al-Rubeaan K, Al Derwish M, Ouizi S, Youssef AM, Subhani SN, Ibrahim HM, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS ONE. 2015;10(5):e124446.
Federation IDIDF. Diabetes Atlas. 7th ed. 2015.
Hu Y, Bakhotmah BA, Alzahrani OH, Wang D, Hu FB, Alzahrani HA. Predictors of diabetes foot complications among patients with diabetes in Saudi Arabia. Diabetes Res Clin Pract. 2014;106(2):286–94.
Selby JV, Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care. 1995;18(4):509–16.
Robinson TE, Kenealy T, Garrett M, Bramley D, Drury PL, Elley CR. Ethnicity and risk of lower limb amputation in people with Type 2 diabetes: a prospective cohort study. Diabet Med. 2016;33(1):55–61.
Young BA, Maynard C, Reiber G, Boyko EJ. Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. Diabetes Care. 2003;26(2):495–501.
Author information
Authors and Affiliations
Contributions
S. Rossboth developed the protocol, conducted the analysis and wrote the manuscript. B. Rossboth assisted in the statistical analysis and the design of the tables and figures. W. Oberaigner was involved in the study design, the conduction of the analysis and writing the article. H. Schoenherr, C. Ciardi and M. Lechleitner contributed their clinical expertise to writing the introduction, results and discussion section. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
S. Rossboth, B. Rossboth, H. Schoenherr, C. Ciardi, M. Lechleitner and W. Oberaigner declare that they have no competing interests.
Ethical standards
All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. The Ethics Committee of the Medical University of Innsbruck approved the present study as part of the Diabetes Registry Tyrol. Due to the retrospective characteristics of the study, no ethics committee approval is required by Austrian law. This information was confirmed by the Ethics Committee of the Medical University of Innsbruck in a general statement. Procedures involving patients, patient data collection, and handling and storage of personal data are in accordance with national laws and the ethical standards of the seventh revision of the Declaration of Helsinki. In addition, the study was approved by the Research Committee for Scientific Ethical Questions at UMIT University. Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rossboth, S., Rossboth, B., Schoenherr, H. et al. Diabetic foot complications—lessons learned from real-world data derived from a specialized Austrian hospital. Wien Klin Wochenschr 134, 7–17 (2022). https://doi.org/10.1007/s00508-021-01864-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-021-01864-5